Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

NCT02652130 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Grade B Acute Graft Versus Host Disease
Grade C Acute Graft Versus Host Disease
Grade D Acute Graft Versus Host Disease

Interventions

BIOLOGICAL: Remestemcel-L

Sponsor

Mesoblast, Inc.

Collaborators

[object Object]